States are increasingly attempting to regulate pharmacy benefit managers (PBMs) to lower prescription drug costs for consumers. Several states passed laws this year to limit PBM compensation, set minimum payments to pharmacists, and demand more transparency, with CVS Health Corp. actively fighting these new regulations. The debate highlights the tension between large PBMs, independent pharmacies, and worried consumers concerned about medication accessibility and affordability.

DA Davidson analyst Michael Baker lowered the price target on Tractor Supply Company (TSCO) from $50 to $40, while maintaining a 'Buy' rating. This adjustment follows a Q1 earnings miss and persistent weak discretionary spending, despite TSCO currently trading at its lowest valuation in a decade on a price-to-earnings basis. The company, a major rural lifestyle retailer, reaffirmed its full-year 2026 guidance, targeting 1% to 3% comparable sales growth.

Roth Capital upgraded APA Corporation (NASDAQ:APA) from 'Neutral' to 'Buy', raising its price objective from $37 to $38, implying an over 14% upside. This upgrade comes as Roth Capital believes global crude prices are nearing a short-term bottom, and many oil exploration and production stocks are now trading at more attractive valuations after declining by 15%-25% from their year-to-date highs. APA Corporation is an independent energy company involved in exploring, developing, and producing natural gas, crude oil, and natural gas liquids, and offers an annual dividend yield of 2.99%.

Paychex, Inc. (NASDAQ: PAYX) announced its Q4 2026 results, reporting adjusted earnings of $1.32 per share, beating expectations by $0.01. Revenue grew 12.5% YoY to $1.61 billion, in line with estimates. For the full year 2026, Paychex achieved 17% YoY revenue growth to $6.5 billion, with significant increases in operating and free cash flow. The company is targeting FY 2027 revenue growth of 5% to 6% and adjusted EPS growth of 7% to 9%.

This article provides an overview of Spyre Therapeutics, Inc. (NASDAQ:SYRE) stock, including its current price, market capitalization, and historical performance. It also details analyst forecasts, financial actuals and estimates, upcoming earnings dates, and general company information. The stock has shown significant growth over the last year, with analysts predicting further potential.

Keurig Dr Pepper (NASDAQ: KDP) has reaffirmed its FY26 guidance for net sales between $25.9 billion and $26.4 billion, alongside targeting low double-digit EPS growth. This announcement comes amidst a significant leadership change, as Rafa Oliveira, head of KDP’s Coffee Operating Unit, is set to depart to become CEO of Heineken, prompting a search for his replacement. The company is also planning to split its vast portfolio into two new US-listed companies: Beverage Co. and Global Coffee Co.

States are increasingly active in regulating pharmacy benefit managers (PBMs) to curb rising drug costs, with several states passing laws this year to enforce transparency, limit compensation, and set minimum payments for pharmacists. CVS, a major PBM that also owns pharmacies, is heavily contesting these regulations, including a new Tennessee law that seeks to bar PBMs from operating retail pharmacies. The debate highlights concerns from independent pharmacists and consumers about affordability and access to medications, while PBMs argue they help lower overall drug costs.

This article provides a price forecast for PT Telkom Indonesia (Persero) Tbk Sponsored ADR Class B (PTI). Based on 20 analysts, the 1-year price target is 17.74. The article also mentions analyst ratings from the past 3 months from 21 analysts, but specific max and min estimates are not provided.

This page provides an overview of Triton International Limited's 7.375% Series C Cumulative Redeemable Perpetual Preference Shares (TRTN/PC), including financial actuals and estimates. It allows users to explore reported financial data across income statements, balance sheets, and cash flow statements. Key financial highlights include the net income for the last quarter at $106.44 million and an EBITDA of $1.11 billion with an 83.67% margin.

This article displays the forward Enterprise Value to EBITDA for LendingTree, Inc. (NASDAQ: TREE) on TradingView. It presents financial data for the company, accessible through various features on the platform. The content is primarily a data display with navigation and platform information.